Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927338 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPTBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC46A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf163 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP8-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CT83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDFY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA5BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFYVE9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on